ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Hence, the suppression of the proliferation of BaF3-T315I cells by cell differentiation induced by I13 may be originated from the repression of the chronic myeloid leukemia signaling pathway via the modulation of BCR-ABL.